<?xml version="1.0" encoding="UTF-8"?>
<p>Nonspecific gastrointestinal symptoms are commonly reported. Diarrhea, nausea and a variety of related complaints were documented in up to 10% of COVID-19 patients in one cohort (Jiang 
 <italic>et al</italic>. 
 <xref rid="bib26" ref-type="bibr">2020</xref>), in 30.0% of MERS patients (Saad 
 <italic>et al</italic>. 
 <xref rid="bib52" ref-type="bibr">2014</xref>) and in 20.3% of SARS patients (Leung 
 <italic>et al</italic>. 
 <xref rid="bib33" ref-type="bibr">2003</xref>). Among SARS patients, watery diarrhea was most often reported in the first week of illness, and the diarrhea did not correlate with mortality or subsequent requirement for supplemental oxygen (Leung 
 <italic>et al</italic>. 
 <xref rid="bib33" ref-type="bibr">2003</xref>); furthermore, Leung and coworkers detected viral particles on biopsy of the small intestine and colon (Leung 
 <italic>et al</italic>. 
 <xref rid="bib33" ref-type="bibr">2003</xref>).
</p>
